Several neuropsychiatric and neurodegenerative disorders are characterised by motivational impairments manifested as lack of behavioural activation or energy resulting in significant functional impairment. Given the clinical significance of these symptoms, the study of motivation in preclinical research has recently intensified. This review briefly summarises the tasks that have been implemented for the evaluation of motivation in different species, emphasising the recent use of touchscreenbased rodent testing systems. This methodology has been widely used in the evaluation of multiple cognitive domains emphasising their translational value and flexibility. Recently touchscreen-based versions of classical tasks for the evaluation of motivation have been or are currently being developed and validated, thus facilitating translation from animal to human research and promoting their implementation in clinical contexts.
Introduction
Motivation is typically defined as the set of adaptive processes by which organisms orient and initiate behaviour towards or away from salient internal and environmental stimuli [1 ,2] . It is complex and multifaceted, encompassing directional, activational and effortrelated components [1 ,3] . To successfully adapt to the environment, organisms must direct and activate appropriate behaviour in response to significant stimuli and assign a suitable degree of effort based on work-related assessments, preferences or motivational value. These abilities are disrupted in a wide range of mental illnesses, including depression, dementia, Huntington's Disease, Parkinson's Disease and schizophrenia [4] [5] [6] [7] .
Clinically, deficits in motivation are typically termed apathy or anergia, which encompass loss or diminishment of goal-directed behaviour and/or cognitive activity [8] and lack of behavioural activation with consequent impairments in important areas of function [9] . These symptoms result in profound functional disability for patients, reduced quality of life for them and their caregivers and can lead to earlier institutionalisation [10] . Despite the highly deleterious nature of these symptoms, there are few targeted therapeutics available for ameliorating them.
To better address this issue, a greater understanding of the neurobiological mechanisms underlying motivation and how these are disrupted in various disease states will be required. The development and optimisation of procedures to assess motivation in preclinical disease models will therefore be of substantial benefit. Ensuring these procedures have high levels of translational validity is also essential to maximise the likelihood of successful delivery of promising therapeutics to the clinic.
Rodent touchscreen-based tests offer a number of advantages including similarity with computerised cognitive assessments increasingly used clinically [11 ] and are versatile pre-clinical tools for the assessment of motivation in rodent models [12 ,13] . In this review we discuss methods for the study of motivation in laboratory rodents and recent developments of tests instantiated in the touchscreen apparatus. Implications for the translation of results obtained in rodents towards the development of therapeutics directed at ameliorating apathy are discussed.
